Original Query: ALL
Previous Study | Return to List | Next Study

Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00784524
Recruitment Status : Terminated (Slow accrual)
First Posted : November 4, 2008
Last Update Posted : April 13, 2015
Information provided by (Responsible Party):
Masonic Cancer Center, University of Minnesota

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Primary Completion Date : July 2014
  Estimated Study Completion Date : December 2015

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 June 21, 2017 July 21, 2017